Iranian Journal of Diabetes and Metabolism is a quarterly published since 2001 in Persian together with English abstracts. The main scope of this journal is to publish original basic and clinical studies in the special field of diabetes and lipid disorders. The members of the editorial board of IJDLD are specialists in the fields of endocrinology and biochemistry selected on the basis of their research background from different parts of the country as well as some international authorities in the relevant fields.
Publishing in IJDLD is free of charge
You can publish in IJDLD free of charge: no payments are required from the Authors. IJDLD doesn’t have article submission charges nor article processing charges (APCs).
The steps toward publishing in IJDLD
The steps toward publishing in IJDLD are the following:
Average lenght of time from author submission of manuscript to final published version of article: 3 months.
Publication Ethics and Publication Malpractice Statement
Our ethic statements are inspired by COPE’s Best Practice Guidelines for Journal Editors.
In particular:
Authorship and Contributorship
Upon publication, the corresponding author must declare that:
Moreover, he/she declares that:
Conflict of Interest Statement and Funding Acknowledgement
In every article a declaration of interest is published.
Upon publication, the corresponding author must declare that:
The corresponding author must also certify that:
Moreover, the corresponding author must declare that:
This policy is based on the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication - Updated April 2010" made by the International Committee of Medical Journal Editors.
Human Rights: Protection of Research Participants and Informed Consent
Considering human experimentation, the authors should write whether the procedures followed were in accordance with the ethical standards of the institutional committee on human experimentation.
If no formal ethics committee is available, the authors should indicate whether the procedures were compliant with the Helsinki Declaration as revised in 2008.
Patients have a right to privacy that should not be violated without informed consent. Identifying information (e.g., names, initials, or hospital numbers) should not be published in written descriptions, photographs, or pedigrees unless the information is needed for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication.
When informed consent has been obtained, the authors should indicate it when submitting the article.
This policy is based on the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication - Updated December 2013" made by the International Committee of Medical Journal Editors.
Animal Rights
Considering experiments on animals, authors should indicate whether institutional and/or national standards for the care and use of laboratory animals were followed. Further guidance on animal research ethics is available from the International Association of Veterinary Editors’ Consensus Author Guidelines on Animal Ethics and Welfare.
This policy is based on the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication - Updated December 2013" made by the International Committee of Medical Journal Editors.
Self-archiving
Authors can archive the
published paper:
Self-archive of preprint and postprint is not permitted instead.
IJDLD's self-archiving policy is indexed in SHERPA/RoMEO.
Screening for plagiarism
The journal staff has a policy of screening for plagiarism. All articles in this publication are original: the content (either in full or in part) in each article has not been knowingly republished without specific citation to the original release. Plagiarism checker is applied randomly to the majority of the papers submitted.
Copyright and publishing rights
Regarding copyright, before publication, Authors declare that, in consideration of the action of IJDLD in reviewing and editing their submission, they transfer, assign, or otherwise convey all copyright ownership, including any and all rights incidental thereto, exclusively to the IJDLD Publisher (Hygeia Press di Corridori Marinella).
Authors have the opportunity to reuse figures, tables and selected text up to 250 words from their article as finally published, providing that full and accurate credit shall be given to publication in IJDLD and that modifications are noted (otherwise no changes may be made).
Disclaimer
Disclaimer. Care has been taken to confirm the accuracy of the information presented and to describe generally accepted practices. However, the authors, editors, and publisher are not responsible for errors or omissions or for any consequences from application of the information in the journal and make no warranty, expressed or implied, with respect to the currency, completeness, or accuracy of the contents of this publication.
Drug dosage. The authors, editors and publisher have exerted every effort to be certain that drug selection and dosage set forth in this issue are in accordance with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any change in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new or infrequently employed drug.
All rights reserved. All materials are protected by Italian law and by international conventions. No part of this work may be translated into other languages, reproduced or utilized in any form or by any means without the prior written permission of the publisher.